Belarusian scientists have developed a new veterinary drug for the treatment of cattle diseases.

The new drug, called Antipestivir-VD, is the first antiviral agent on the market effective against mucosal diseases in cows, including latent infections. It contains components produced from locally available raw materials that activate the animal's immune response. In clinical trials, the drug demonstrated high efficacy: 63.3% of animals recovered within 4-5 days, significantly faster than traditional treatments.

Production of Antipestivir-VD has already begun, and its potential export to the EAEU countries and other regions is expected after registration.